Validity and Reliability of Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Iranian People with Parkinson's Disease.

IF 2.1 4区医学 Q3 CLINICAL NEUROLOGY Parkinson's Disease Pub Date : 2020-08-18 eCollection Date: 2020-01-01 DOI:10.1155/2020/2793945

Maryam Mehdizadeh, Seyed-Mohammad Fereshtehnejad, Sepide Goudarzi, Ainaz Moshtagh, Farzaneh Dehghanian Nasrabadi, Sayed Amir Hasan Habibi, Ghorban Taghizadeh

{"title":"Validity and Reliability of Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Iranian People with Parkinson's Disease.","authors":"Maryam Mehdizadeh, Seyed-Mohammad Fereshtehnejad, Sepide Goudarzi, Ainaz Moshtagh, Farzaneh Dehghanian Nasrabadi, Sayed Amir Hasan Habibi, Ghorban Taghizadeh","doi":"10.1155/2020/2793945","DOIUrl":null,"url":null,"abstract":"Purpose: Pain is one of the nonmotor symptoms of Parkinson's disease (PD) that, in order to be better managed, requires to be evaluated. Evaluations are done using pain assessment scales such as the Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2). The goal of this study was to assess the psychometric properties of SF-MPQ-2 to measure pain in people with PD.Methods: Four hundred and twenty-eight PD patients with a mean (SD) age of 60.11 (11.44) years were included. Accessibility was measured through floor and ceiling effects. Dimensionality was estimated by exploratory factor analysis. The association between SF-MPQ-2 and other scales such as Neuropathic Pain Symptom Inventory, Douleur Neuropathic 4, Brief Pain Inventory, King's Pain Parkinson's Disease Scale, and Visual Analog Scale-Pain was considered to calculate convergent validity. Internal consistency and test-retest reliability were assessed by Cronbach's alpha and intraclass correlation coefficient (ICC), respectively.Results: A noticeable floor effect was found. Dimensionality results indicated four factors for this scale. A strong relationship was found between the SF-MPQ-2 total score and other scales (r = 0.55 to 0.85). In reliability analysis, Cronbach's alpha and ICC were 0.93 and 0.94 for SF-MPQ-2, respectively.Conclusion: The results of this study showed that SF-MPQ-2 has adequate validity and reliability to measure pain in people with Parkinson's disease.","PeriodicalId":19907,"journal":{"name":"Parkinson's Disease","volume":"2020 ","pages":"2793945"},"PeriodicalIF":2.1000,"publicationDate":"2020-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/2793945","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Parkinson's Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2020/2793945","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 8

Abstract

Purpose: Pain is one of the nonmotor symptoms of Parkinson's disease (PD) that, in order to be better managed, requires to be evaluated. Evaluations are done using pain assessment scales such as the Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2). The goal of this study was to assess the psychometric properties of SF-MPQ-2 to measure pain in people with PD.

Methods: Four hundred and twenty-eight PD patients with a mean (SD) age of 60.11 (11.44) years were included. Accessibility was measured through floor and ceiling effects. Dimensionality was estimated by exploratory factor analysis. The association between SF-MPQ-2 and other scales such as Neuropathic Pain Symptom Inventory, Douleur Neuropathic 4, Brief Pain Inventory, King's Pain Parkinson's Disease Scale, and Visual Analog Scale-Pain was considered to calculate convergent validity. Internal consistency and test-retest reliability were assessed by Cronbach's alpha and intraclass correlation coefficient (ICC), respectively.

Results: A noticeable floor effect was found. Dimensionality results indicated four factors for this scale. A strong relationship was found between the SF-MPQ-2 total score and other scales (r = 0.55 to 0.85). In reliability analysis, Cronbach's alpha and ICC were 0.93 and 0.94 for SF-MPQ-2, respectively.

Conclusion: The results of this study showed that SF-MPQ-2 has adequate validity and reliability to measure pain in people with Parkinson's disease.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

伊朗帕金森病患者短格式McGill疼痛问卷-2 (SF-MPQ-2)的效度和信度

目的:疼痛是帕金森病(PD)的非运动症状之一，为了更好地治疗，需要对其进行评估。评估使用疼痛评估量表，如短格式麦吉尔疼痛问卷-2 (SF-MPQ-2)。本研究的目的是评估SF-MPQ-2的心理测量特性，以测量PD患者的疼痛。方法:纳入428例PD患者，平均(SD)年龄为60.11(11.44)岁。可达性是通过地板和天花板效应来衡量的。通过探索性因子分析估计维度。SF-MPQ-2与其他量表如神经性疼痛症状量表、Douleur神经性疼痛量表、短暂疼痛量表、King’s Pain帕金森病量表和视觉模拟疼痛量表之间的关联被认为是计算收敛效度的依据。内部一致性和重测信度分别采用Cronbach’s alpha和class内相关系数(ICC)进行评估。结果:有明显的地板效应。维度结果显示了该量表的四个因素。SF-MPQ-2总分与其他量表有较强的相关性(r = 0.55 ~ 0.85)。在信度分析中，SF-MPQ-2的Cronbach’s alpha和ICC分别为0.93和0.94。结论:本研究结果表明SF-MPQ-2测量帕金森病患者疼痛具有足够的效度和信度。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Parkinson's Disease CLINICAL NEUROLOGY-

CiteScore

5.80

自引率

3.10%

发文量

审稿时长

18 weeks

期刊介绍： Parkinson’s Disease is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the epidemiology, etiology, pathogenesis, genetics, cellular, molecular and neurophysiology, as well as the diagnosis and treatment of Parkinson’s disease.